# Predicting Bispectral Index Values by Estimated Effect-site Concentration of Propofol and Remifentanil Displayed on the Target-centered Infusion Pump

> **NCT01604226** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- General Anesthesia
- Total Intravenous Anesthesia
- Bispectral Index Monitoring

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01604226
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01604226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01604226, "Predicting Bispectral Index Values by Estimated Effect-site Concentration of Propofol and Remifentanil Displayed on the Target-centered Infusion Pump". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01604226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*